CA3005885A1 - Pastilles de cannabinoide a liberation continue - Google Patents

Pastilles de cannabinoide a liberation continue Download PDF

Info

Publication number
CA3005885A1
CA3005885A1 CA3005885A CA3005885A CA3005885A1 CA 3005885 A1 CA3005885 A1 CA 3005885A1 CA 3005885 A CA3005885 A CA 3005885A CA 3005885 A CA3005885 A CA 3005885A CA 3005885 A1 CA3005885 A1 CA 3005885A1
Authority
CA
Canada
Prior art keywords
cannabinoid
mixture
composition according
slurry
pellets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3005885A
Other languages
English (en)
Inventor
Jeff Scott Renwick
Robert Lefler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canntab Therapeutics Ltd
Original Assignee
Canntab Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/923,095 external-priority patent/US20180263954A1/en
Application filed by Canntab Therapeutics Ltd filed Critical Canntab Therapeutics Ltd
Publication of CA3005885A1 publication Critical patent/CA3005885A1/fr
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3005885A 2017-08-30 2018-05-23 Pastilles de cannabinoide a liberation continue Pending CA3005885A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762551924P 2017-08-30 2017-08-30
US62/551,924 2017-08-30
US15/923,095 2018-03-16
US15/923,095 US20180263954A1 (en) 2016-09-27 2018-03-16 Sustained Release Cannabinoid Formulations

Publications (1)

Publication Number Publication Date
CA3005885A1 true CA3005885A1 (fr) 2019-02-28

Family

ID=65519433

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3005885A Pending CA3005885A1 (fr) 2017-08-30 2018-05-23 Pastilles de cannabinoide a liberation continue

Country Status (1)

Country Link
CA (1) CA3005885A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2618322A (en) * 2022-04-29 2023-11-08 113 Botanicals Ltd Compositions and methods

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2618322A (en) * 2022-04-29 2023-11-08 113 Botanicals Ltd Compositions and methods

Similar Documents

Publication Publication Date Title
CA3036585A1 (fr) Formulations de cannabinoides a liberation prolongee
AU2018233582B2 (en) Modified release multi-layer tablet cannabinoid formulations
US11590230B2 (en) Compositions of therapeutic substances, methods and uses thereof
US20180263953A1 (en) Sustained Release Cannabinoid Formulations
RU2385712C2 (ru) Рецептура с контролируемым высвобождением
CA2981772C (fr) Formulations orales solides de cannabinoides, leurs procedes de production et d'utilisation
BR112021001326A2 (pt) formulações de liberação prolongada de canabinoides
AU2016347651A1 (en) Novel cannabinoid formulations
JP2021535935A (ja) ナノ乳化による製剤化カンナビス油粉末、その製造方法、及びその使用
CA3149966A1 (fr) Comprimes de cannabidiol a desintegration orale
JP4783573B2 (ja) ワルファリンカリウム含有医薬組成物とその製造方法
US20180263954A1 (en) Sustained Release Cannabinoid Formulations
US20180250262A1 (en) Sustained release cannabinoid formulations
TW201726113A (zh) 易服用性固態製劑用粒子組成物及含有該粒子組成物之易服用性固態製劑
JP5450483B2 (ja) ワルファリンカリウム含有医薬組成物とその製造方法
CA3005885A1 (fr) Pastilles de cannabinoide a liberation continue
CA3005889A1 (fr) Formulations de cannabinoide a liberation continue
WO2010103539A2 (fr) Formulation orale de vinpocétine à libération lente
WO2023015378A1 (fr) Stabilisation de résine de cannabis et formulations orales solides de cannabinoïdes
JP4575717B2 (ja) アンピロキシカム含有医薬組成物とその安定化方法及びその製造方法
CN102552358B (zh) 一种水飞蓟素组合物及其制备方法
AU2021414679A1 (en) Water-soluble cannabinoid formulation and preparation method therefor
Martínez et al. Trends in oral flavonoid drug delivery systems based on current pharmaceutical strategies. A systematic patent review (2011-2023)
DK177906B1 (en) Dispersible tablet
JP2020094023A (ja) 賦形剤顆粒、錠剤及び錠剤の製造方法